1GManis E, Buckner JC, dDinapoli RP, et aL. Clinical outcome of gliosarcoma compared with glioblastoma multi- forme: North Central Cancer Treat ment Group resuhs[J]. J Neurosurg, 19t)8,89(3) :425 30.
2Meis JM, Martz KI., Nelson .IS. Mixed glioblastoma nmltiforme and sarcoma. A clinicopathologic study ot 26 radiation therapyoncology group cases[J]. Canc- er, 1991,67(9) :2342-9.
3Okami N, Kawamata T, Kubo 0, et al. Infantile gliosarcoma: a case and a re- view of the literature [J]. Childs Nerv Syst,2002,18(6 7) :351-5.
4Wolljer RI.. Weil RJ, Moots PI., et al. Pathologic quiz case:cerebell:tr hemor rh:ge in an octogenarian,Gliosarcona [J].Arch Pathol Lab Med,2003,127 (8) ,e345 -6.
5Pakos EE, Goussia AC, Zina VP, et al. Multi focal gliosarcoma:a case report and review of the literature [J].Neurooncol 02t1115,74(3) :301-4.
6Ghods AJ, Irvin D. l.iu G. et al. Spheres isolated frmn 9I. gliosarcoma rat cell line possess chemoresistanl and ag gressive cancer s'tem- like cells[J]. Stem Cells.2007,25(7) : 1645-53.
7Machuca TN, Prevedello DM, Pope I.Z et al. Gliosarcoma:report of four ca ses with immunohistochemical find ings E[J]. Arg Neuropsiquiatr, 2004 62(3A) :608-12.
8"I:lkagaki M, Powell W, Sook A, et al. P, oronated dipeptide borotrimelhylg lycylphenylalaninc as a potential bo- ron carrier ill boron neutron caplure therapy for malignant brain tumors [J]. Radiat Res, 2001, 156 ( 1 ): 118-22.
9Ealvati M,Caroli E, Raeo A, et al. Glio- sarcomas: analysis of 11 cases do two subtypes exist [J]. J Neurooncol, 21)05,74( 1 ): 59-63.
